Wednesday, March 19, 2008

Report: Biogen Idec CEO predicts more brain disorders in Tysabri ...

Report: Biogen Idec CEO predicts more brain disorders in Tysabri ...
Bizjournals.com - Charlotte,NC,USA
The CEO of Biogen Idec told investors Tuesday that he expects to see more cases of a rare, fatal brain disorder in patients taking the drug Tysabri, ...
See all stories on this topic

Last taping of the 'The Montel Williams Show' isn't the end
New York Daily News - New York,NY,USA
During that time, viewers have seen Williams go through a divorce, other turmoils and the shocking revelation he's got multiple sclerosis. ...
See all stories on this topic

Peptimmune Completes Phase I Study With A Novel Peptide Copolymer For The Treatment Of Multiple Sclerosis
Medical News Today Wed, 19 Mar 2008 1:08 AM PDT
Peptimmune, Inc. a privately held biotechnology company, announced that it has completed its first clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PI-2301, a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
Cognitive Impairment Without Dementia Affects 5 Million Elderly Americans
A new study by researchers in the US suggests over 5 million elderly Americans below the threshold for dementia have cognitive impairment that reduces the performance of memory, thinking and other faculties.
Immune Systems Increasingly On Attack
Washington Post Tue, 18 Mar 2008 5:46 PM PDT
First, asthma cases shot up, along with hay fever and other common allergic reactions, such as eczema. Then, pediatricians started seeing more children with food allergies. Now, experts are increasingly convinced that a suspected jump in lupus, multiple sclerosis and other afflictions caused by m...
Regrowing Limbs: Can People Regenerate Body Parts?: Scientific American
Progress on the road to regenerating major body parts, salamander-style, could transform the treatment of amputations and major wounds
Two House Members Introduce Bill To Allow FDA To Approve Generic Versions Of Biotechnology Medications
Reps. Anna Eshoo (D-Calif.) and Joe Barton (R-Texas) on Thursday introduced a bill that would allow FDA to approve generic versions of biotechnology medications, CongressDaily reports.
Rx For High Drug Prices - New Book Presents A Solution
The mounting U.S. drug price crisis can be contained and eventually reversed by separating drug discovery from drug marketing and by establishing a non-profit company to oversee funding for new medicines, according to two MIT experts on the pharmaceutical industry.18 Mar 2008

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home